Equities research analysts at William Blair decreased their FY2026 earnings per share estimates for shares of Bristol-Myers ...
Equities research analysts at William Blair upped their FY2025 EPS estimates for shares of Modine Manufacturing in a note ...
The buy now/pay later lender outperformed nearly every analyst estimate in its fiscal Q2 2025 earnings report. CEO Max Levchin said the company is 5 months out from positive GAAP operating income.
Fintel reports that on February 7, 2025, William Blair downgraded their outlook for WEX (NYSE:WEX) from Outperform to Market ...